Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $1.50
7% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $16.0K | $43.1K | $98.5K | $31.3K |
| Cost of revenue | $75.0K | $164.4K | $1.8K | $26.4K | $23.7K |
| Gross profit | −$75.0K | −$148.4K | $41.3K | $72.1K | $18.9K |
| Gross margin | — | -924.6% | 95.8% | 73.2% | 60.4% |
| R&D | $112.4K | $61.7K | $500 | $0 | $2.9K |
| Operating income | −$1.6M | −$1.8M | −$767.1K | −$377.6K | −$346.4K |
| EBITDA | −$1.4M | −$1.6M | −$1.8M | −$319.5K | −$328.9K |
| Net income | −$1.6M | −$1.9M | −$1.8M | −$339.8K | −$328.9K |
| Net margin | — | -12084.5% | -4134.7% | -344.9% | -1052.2% |
| EPS (diluted) | -0.04 | -0.05 | -0.04 | -0.08 | -0.07 |
Annual figures · source: Financial Modeling Prep
DOSEOLOGY SCIENCES INC
No one on the platform currently holds DOSEF.
No tracked institution reports a position in DOSEF as of their last filing.
| Execution date | Ratio |
|---|---|
| 2024-02-16 | 1-for-10reverse |
No one on the platform has traded DOSEF yet.
| $4M |
| — |
| FAMDFFutura Medical plc | $0.00 | -70.00% | $712597 | — |
| FNAMEvolutionary Genomics, Inc. | $0.00 | +0.00% | $1331 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 10.6× sales vs its 193.1× historical median P/S.
Fair value ≈ $2.03 · price $0.11 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Does this financing extension allow them to bring in better or larger investors or partners? $MOOD.CSE $DOSEF
View on StockTwits ↗$DOSEF [15s. delayed]: Issued Press Release on May 05, 13:36:00: Doseology Announces New Director and Corporate Secretary https://s.flashalert.me/H2Wjs
View on StockTwits ↗$DOSEF Doseology Announces New Director and Corporate Secretary https://www.stocktitan.net/news/DOSEF/doseology-announces-new-director-and-corporate-804ct86h2rbx.html
View on StockTwits ↗$DOSEF [15s. delayed]: Issued Press Release on March 31, 09:00:00: Doseology Announces CEO Transition https://s.flashalert.me/WDTIT
View on StockTwits ↗$DOSEF Doseology Announces CEO Transition https://www.stocktitan.net/news/DOSEF/doseology-announces-ceo-7u24achpsakw.html
View on StockTwits ↗$DOSEF [15s. delayed]: Issued Press Release on March 03, 08:00:00: Doseology Welcomes New CFO https://s.flashalert.me/KDiSN
View on StockTwits ↗$DOSEF Doseology Welcomes New CFO https://www.stocktitan.net/news/DOSEF/doseology-welcomes-new-m27hfjbd6mme.html
View on StockTwits ↗$DOSEF Doseology Provides Corporate Update https://www.stocktitan.net/news/DOSEF/doseology-provides-corporate-a9drpeg5oo2r.html
View on StockTwits ↗$DOSEF Doseology Uplists to OTCQB Market in USA https://www.stocktitan.net/news/DOSEF/doseology-uplists-to-otcqb-market-in-q4zqk0s8aehi.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.